1-20 of 186
Philippe Armand
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 1 Dose Escalation Study of Igm-2323, a Novel Anti-CD20 x Anti-CD3 IgM T Cell Engager (TCE) in Patients with Advanced B-Cell Malignancies

Elizabeth Budde, Ajay K Gopal, Won Seog Kim, Ian W. Flinn, Chan Yoon Y. Cheah, Loretta Nastoupil, Matthew J. Matasar, Catherine S. Diefenbach, Gareth P Gregory, Ibrahim Qazi, Ching-Fai Pang, Maya Leabman, Genevive Hernandez, Iris Sison, Bruce A. Keyt, Daniel Chen, Philippe Armand
Journal: Blood
Blood (2021) 138 (Supplement 1): 132.
DOI: https://doi.org/10.1182/blood-2021-153355
Published: 2021
Journal Articles

Safety and Efficacy Profile of Autologous CD30.CAR-T-Cell Therapy in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma (CHARIOT Trial)

Sairah Ahmed, Ian W. Flinn, Matthew Mei, Peter A. Riedell, Philippe Armand, Natalie S Grover, Andreas Engert, Natalia Lapteva, Paul I. Nadler, Aung Myo, Helen E. Heslop
Journal: Blood
Blood (2021) 138 (Supplement 1): 3847.
DOI: https://doi.org/10.1182/blood-2021-146100
Published: 2021
Journal Articles

Longer Term Follow-up of a Multicenter, Phase 2 Study of Ibrutinib Plus Fludarabine, Cyclophosphamide, Rituximab (iFCR) As Initial Therapy for Younger Patients with Chronic Lymphocytic Leukemia

Matthew S. Davids, Danielle M. Brander, Svitlana Tyekucheva, Chinheng Chen, James Kaminski, Josie Montegaard, Alvaro J. Alencar, Leyla Shune, Mohammad Omaira, Caron Jacobson, Philippe Armand, Samuel Y. Ng, Jennifer L. Crombie, Ann S. LaCasce, Jon E. Arnason, Ephraim Hochberg, Ronald W. Takvorian, Jeremy S. Abramson, David C. Fisher, Jennifer R Brown
Journal: Blood
Blood (2021) 138 (Supplement 1): 640.
DOI: https://doi.org/10.1182/blood-2021-146624
Published: 2021
Journal Articles

Final Analysis of Keynote-170: Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL)

Pier Luigi Luigi Zinzani, Catherine Thieblemont, Vladimir Melnichenko, Krimo Bouabdallah, Jan Waleswski, Alejandro Majlis, Laura Fogliatto, Alejandro Martin Garcia-Sancho, Beth Christian, Zafer Gulbas, Muhit Özcan, Guilherme Fleury Perini, Gilles Salles, Margaret A. Shipp, Seth Thompson, Samhita Chakraborty, Patricia Marinello, Philippe Armand
Journal: Blood
Blood (2021) 138 (Supplement 1): 306.
DOI: https://doi.org/10.1182/blood-2021-148082
Published: 2021
Journal Articles

Prognostic Value of Minimal Residual Disease (MRD) Among Patients with Classical Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation

Eleanor Taranto, Robert A. Redd, Erin Jeter, Kristin M McHugh, Jennifer R Brown, Jennifer L. Crombie, Matthew S. Davids, David C. Fisher, Arnold S. Freedman, Eric D Jacobsen, Caron Jacobson, Austin I. Kim, Ann S. LaCasce, Benjamin L. Lampson, Samuel Y. Ng, Oreofe O. Odejide, Erin Michelle Parry, Parastoo B. Dahi, Yago Nieto, Robin M. Joyce, Yi-Bin Chen, Alex F. Herrera, Philippe Armand, Reid W Merryman
Journal: Blood
Blood (2021) 138 (Supplement 1): 3491.
DOI: https://doi.org/10.1182/blood-2021-147263
Published: 2021
Journal Articles

Five-Year Follow-up of Keynote-087: Pembrolizumab Monotherapy in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL)

Philippe Armand, Pier Luigi Luigi Zinzani, Hun Ju Lee, Nathalie Johnson, Pauline Brice, John Radford, Vincent Ribrag, Daniel Molin, Theodoros P. Vassilakopoulos, Akihiro Tomita, Bastian von Tresckow, Margaret A. Shipp, Alex F. Herrera, Jianxin Lin, Eunhee Kim, Samhita Chakraborty, Patricia Marinello, Craig H. Moskowitz
Journal: Blood
Blood (2021) 138 (Supplement 1): 1366.
DOI: https://doi.org/10.1182/blood-2021-147881
Published: 2021
Journal Articles

Prognostic Value of Early PET in Patients with Aggressive Non-Hodgkin Lymphoma Treated with Anti-CD19 CAR T-Cell Therapy

Jennifer L. Crombie, Robert A. Redd, Victor A. Chow, Jordan Gauthier, Erin Mullane, Geoffrey Shouse, Alex F. Herrera, Jason Romancik, Jonathon B. Cohen, Anna Saucier, Roch Houot, Caron Jacobson, Philippe Armand, Brian T. Hess
Journal: Blood
Blood (2021) 138 (Supplement 1): 886.
DOI: https://doi.org/10.1182/blood-2021-152819
Published: 2021
Journal Articles

Characterizing Safety in Patients with Hematologic Malignancies Receiving Allogeneic Stem Cell Transplant (Allo-SCT) Following Pembrolizumab Therapy

Philippe Armand, John Kuruvilla, Alex F. Herrera, Vincent Ribrag, Pauline Brice, Catherine Thieblemont, Bastian Von Tresckow, Eunhee Kim, Robert Orlowski, Samhita Chakraborty, Patricia Marinello, Pier Luigi Luigi Zinzani
Journal: Blood
Blood (2021) 138 (Supplement 1): 3924.
DOI: https://doi.org/10.1182/blood-2021-148528
Published: 2021
Journal Articles

Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation

Clinical Trials & Observations Brief Report
Livius Penter, Yi Zhang, Alexandra Savell, Teddy Huang, Nicoletta Cieri, Emily M. Thrash, Seunghee Kim-Schulze, Aashna Jhaveri, Jingxin Fu, Srinika Ranasinghe, Shuqiang Li, Wandi Zhang, Emma S. Hathaway, Matthew Nazzaro, Haesook T. Kim, Helen Chen, Magdalena Thurin, Scott J. Rodig, Mariano Severgnini, Carrie Cibulskis, Stacey Gabriel, Kenneth J. Livak, Corey Cutler, Joseph H. Antin, Sarah Nikiforow, John Koreth, Vincent T. Ho, Philippe Armand, Jerome Ritz, Howard Streicher, Donna Neuberg, F. Stephen Hodi, Sacha Gnjatic, Robert J. Soiffer, X. Shirley Liu, Matthew S. Davids, Pavan Bachireddy, Catherine J. Wu
Journal: Blood
Blood (2021) 137 (23): 3212–3217.
DOI: https://doi.org/10.1182/blood.2021010867
Published: 2021
Includes: Supplemental data
Journal Articles

Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma

Gabriel K. Griffin, Jason L. Weirather, Margaretha G. M. Roemer, Mikel Lipschitz, Alyssa Kelley, Pei-Hsuan Chen, Daniel Gusenleitner, Erin Jeter, Christine Pak, Evisa Gjini, Bjoern Chapuy, Michael H. Rosenthal, Jie Xu, Benjamin J. Chen, Aliyah R. Sohani, Scott B. Lovitch, Jeremy S. Abramson, Jeffrey J. Ishizuka, Austin I. Kim, Caron A. Jacobson, Ann S. LaCasce, Christopher D. Fletcher, Donna Neuberg, Gordon J. Freeman, F. Stephen Hodi, Kyle Wright, Azra H. Ligon, Eric D. Jacobsen, Philippe Armand, Margaret A. Shipp, Scott J. Rodig
Journal: Blood
Blood (2021) 137 (10): 1353–1364.
DOI: https://doi.org/10.1182/blood.2020006464
Published: 2021
Includes: Supplemental data
Journal Articles

Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphoma

Clinical Trials & Observations
Philippe Armand, Ann Janssens, Giuseppe Gritti, John Radford, John Timmerman, Antonio Pinto, Santiago Mercadal Vilchez, Peter Johnson, David Cunningham, John P. Leonard, Scott J. Rodig, Patricia Martín-Regueira, Anne Sumbul, Selda Samakoglu, Hao Tang, Stephen M. Ansell
Journal: Blood
Blood (2021) 137 (5): 637–645.
DOI: https://doi.org/10.1182/blood.2019004753
Published: 2021
Includes: Supplemental data
Journal Articles

A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma

Clinical Trials & Observations
Nancy L. Bartlett, Alex F. Herrera, Eva Domingo-Domenech, Amitkumar Mehta, Andres Forero-Torres, Ramon Garcia-Sanz, Philippe Armand, Sumana Devata, Antonia Rodriguez Izquierdo, Izidore S. Lossos, Craig Reeder, Taimur Sher, Robert Chen, Sylvia E. Schwarz, Leila Alland, Andras Strassz, Kim Prier, Cassandra Choe-Juliak, Stephen M. Ansell
Journal: Blood
Blood (2020) 136 (21): 2401–2409.
DOI: https://doi.org/10.1182/blood.2019004701
Published: 2020
Includes: Supplemental data
Journal Articles

Prognostic Value of Circulating Tumor DNA (ctDNA) in Autologous Stem Cell Graft and Post-Transplant Plasma Samples Among Patients with Diffuse Large B-Cell Lymphoma

Reid W Merryman, MD, Robert A. Redd, MS, Eleanor Taranto, MD, Gulrayz Ahmed, MD, Erin Jeter, Kristin M McHugh, Jennifer R. Brown, MD PhD, Jennifer Crombie, MD, Matthew S. Davids, MD, David C. Fisher, MD, Arnold S. Freedman, MD, Eric Jacobsen, MD, Caron Jacobson, MD MMSc, Austin I. Kim, MD, Ann S. LaCasce, MD MSc, Benjamin L. Lampson, MD PhD, Samuel Ng, MD PhD, Oreofe O. Odejide, MDMPH, Parastoo B. Dahi, MD, Yago Nieto, MD, Robin M. Joyce, MD, Yi-Bin Chen, MD, Alex F. Herrera, MD, Philippe Armand, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 22–23.
DOI: https://doi.org/10.1182/blood-2020-140965
Published: 2020
Journal Articles

Updated Safety and Efficacy Results from a Phase 2 Study of Acalabrutinib, Venetoclax and Obinutuzumab (AVO) for Frontline Treatment of Chronic Lymphocytic Leukemia (CLL)

Matthew S. Davids, MD, Benjamin L. Lampson, MD PhD, Svitlana Tyekucheva, PhD, Jennifer L. Crombie, MD, Samuel Ng, MD PhD, Austin I. Kim, MD, Matthew Weinstock, MD, Jessica Lowney, Samantha Pazienza, Josie Montegaard, NP, Victoria Patterson, BSN, RN, Caron A. Jacobson, MD, Ann S. LaCasce, MD MSc, Philippe Armand, MD PhD, Jon E. Arnason, MD, David C. Fisher, MD, Jennifer R. Brown, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 20–21.
DOI: https://doi.org/10.1182/blood-2020-139864
Published: 2020
Journal Articles

Pembrolizumab Monotherapy in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL): 3-Year Follow-up of the Keynote-170 Study

Pier Luigi Zinzani, MD, Vladimir Melnichenko, Krimo Bouabdallah, MD, Jan Walewski, MD PhD, Alejandro Majlis, MD, Laura Fogliatto, MDPhD, Dolores Caballero, MD PhD, Beth A. Christian, MD, Zafer Gulbas, MD, Muhit Özcan, MD, Gilles Salles, MD PhD, Margaret A. Shipp, MD, Seth Thompson, Robert J Orlowski, MD, Patricia Marinello, Philippe Armand, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 42–43.
DOI: https://doi.org/10.1182/blood-2020-137080
Published: 2020
Journal Articles

Preliminary Results of a Phase 1 Dose Escalation Study of the First-in-Class IgM Based Bispecific Antibody Igm-2323 (anti-CD20 x anti-CD3) in Patients with Advanced B-Cell Malignancies

Elizabeth Budde, MDPhD, Ajay K. Gopal, MD, Ian W. Flinn, MD PhD, Loretta J. Nastoupil, MD, Michael S. Gordon, MD, Ching-Fai Pang, PhD, Bruce Keyt, PhD, Steve Carroll, PhD, Maya Leabman, PhD, Genevive Hernandez, PhD, Iris Sison, Daniel Chen, MD PhD, Wayne Godfrey, MD, Philippe Armand, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 45–46.
DOI: https://doi.org/10.1182/blood-2020-134983
Published: 2020
Journal Articles

Interim Positron Emission Tomography (iPET) Assessed Using Deauville Score for Patients with Follicular Lymphoma Receiving First-Line Chemoimmunotherapy

Reid W Merryman, MD, Gabriela Spilberg, MD, Patrizia Mondello, MDPhDMSc, Robert A. Redd, MS, Eleanor Taranto, MD, Gulrayz Ahmed, MD, Erin Jeter, Matthew Chase, MD, Gilles Salles, MDPhD, Andrew D Zelenetz, MD PhD, Jennifer R Brown, MD PhD, Jennifer Crombie, MD, Matthew S. Davids, MD, David C. Fisher, MD, Arnold S. Freedman, MD, Eric D Jacobsen, MD, Caron A. Jacobson, MD, Austin I. Kim, MD, Ann S. LaCasce, MD MSc, Benjamin L. Lampson, MD PhD, Samuel Y. Ng, MDPhD, Oreofe Odejide, MD, Philippe Armand, MD PhD, Heather A. Jacene, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
DOI: https://doi.org/10.1182/blood-2020-135919
Published: 2020
Journal Articles

R-CHOP Versus R-Bendamustine with or without Rituximab Maintenance in Newly Diagnosed Follicular Lymphoma Patients with High SUV at Baseline PET

Patrizia Mondello, MDPhDMSc, Paolo Strati, MD, Reid W Merryman, MD, Erel Joffe, MD MSc, Marco Ruella, MD, Venkatraman Seshan, PhD, Frederique St Pierre, Ajay Major, MDMBA, Priyanka Pophali, MD, Megan Fiasconaro, Carrie I Ho, MD, Eleanor Neal, Chao-Ming Lai, Gabriela Spilberg, MD, Saurabh Rajguru, MD, Jakub Svoboda, MD, Thomas E. Witzig, MD, Sonali M. Smith, MD, Philippe Armand, MD PhD, Loretta J. Nastoupil, MD, Stephen M. Ansell, MD PhD, Andrew D Zelenetz, MD PhD, Anas Younes, Gilles Salles
Journal: Blood
Blood (2020) 136 (Supplement 1): 39–40.
DOI: https://doi.org/10.1182/blood-2020-136438
Published: 2020
Journal Articles

A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantation

Clinical Trials & Observations
Matthew S. Davids, Haesook T. Kim, Caitlin Costello, Alex F. Herrera, Frederick L. Locke, Rodrigo O. Maegawa, Alexandra Savell, Michael Mazzeo, Adrienne Anderson, Alexander P. Boardman, Augustine Weber, David Avigan, Yi-Bin Chen, Sarah Nikiforow, Vincent T. Ho, Corey Cutler, Edwin P. Alyea, Pavan Bachireddy, Catherine J. Wu, Jerome Ritz, Howard Streicher, Edward D. Ball, Asad Bashey, Robert J. Soiffer, Philippe Armand
Journal: Blood
Blood (2020) 135 (24): 2182–2191.
DOI: https://doi.org/10.1182/blood.2019004710
Published: 2020
Includes: Supplemental data
Journal Articles

The microenvironmental niche in classic Hodgkin lymphoma is enriched for CTLA-4–positive T cells that are PD-1–negative

Sanjay S. Patel, Jason L. Weirather, Mikel Lipschitz, Ana Lako, Pei-Hsuan Chen, Gabriel K. Griffin, Philippe Armand, Margaret A. Shipp, Scott J. Rodig
Journal: Blood
Blood (2019) 134 (23): 2059–2069.
DOI: https://doi.org/10.1182/blood.2019002206
Published: 2019
Includes: Supplemental data